We are live on ! Find out more
Nebula Research & Development

Nebula Research & Development Portfolio holdings

AUM $1.17B Turnover 43.96%
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$92.8M
Cap. Flow
+$15.3M
Cap. Flow %
1.3%
Top 10 Hldgs %
4.44%
Holding
1,192
New
267
Increased
346
Reduced
321
Closed
257
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.1 years

Top Buys

Rank Stock Value
1
LRN icon
Stride
LRN
+$5.17M
2
FDX icon
FedEx
FDX
+$4.67M
3
QSR icon
Restaurant Brands International
QSR
+$4.66M
4
LKQ icon
LKQ Corp
LKQ
+$4.61M
5
AAL icon
American Airlines Group
AAL
+$4.59M

Sector Composition

Rank Sector Weight
1 Technology 18.31%
2 Industrials 15.93%
3 Consumer Discretionary 15.09%
4 Healthcare 11.66%
5 Financials 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AN icon
226
AutoNation
AN
$5.8B
$1.74M 0.15%
+8,778
New +$1.58M
2025 Q2
0 quarters
CAH icon
227
Cardinal Health
CAH
$58B
$1.74M 0.15%
10,334
+2,646
+34% +$393K
2025 Q1
1 quarter
BGC icon
228
BGC Group
BGC
$5.24B
$1.73M 0.15%
169,341
+82,360
+95% +$756K
2024 Q3
3 quarters
DTE icon
229
DTE Energy
DTE
$28.2B
$1.73M 0.15%
+13,043
New +$1.75M
2025 Q2
0 quarters
VLTO icon
230
Veralto
VLTO
$27B
$1.72M 0.15%
17,020
-32,585
-66% -$3.14M
2024 Q1
5 quarters
CPNG icon
231
Coupang
CPNG
$25.8B
$1.71M 0.15%
57,180
-29,552
-34% -$757K
2023 Q3
7 quarters
SEM icon
232
DELISTED
Select Medical
SEM
$1.71M 0.15%
+112,364
New +$1.75M
2025 Q2
0 quarters
MET icon
233
MetLife
MET
$63.6B
$1.68M 0.14%
+20,939
New +$1.62M
2025 Q2
0 quarters
SRPT icon
234
Sarepta Therapeutics
SRPT
$1.97B
$1.68M 0.14%
+98,075
New +$4.18M
2025 Q2
0 quarters
SNAP icon
235
Snap
SNAP
$9.03B
$1.67M 0.14%
+192,706
New +$1.6M
2025 Q2
0 quarters
HLI icon
236
Houlihan Lokey
HLI
$9.6B
$1.67M 0.14%
9,273
+5,001
+117% +$840K
2024 Q4
2 quarters
RAMP icon
237
LiveRamp
RAMP
$2.34B
$1.65M 0.14%
50,011
-9,616
-16% -$279K
2024 Q3
3 quarters
EG icon
238
Everest Group
EG
$15.4B
$1.65M 0.14%
4,858
+2,897
+148% +$999K
2024 Q4
2 quarters
QLYS icon
239
Qualys
QLYS
$7.75B
$1.65M 0.14%
11,547
-3,259
-22% -$431K
2024 Q4
2 quarters
EL icon
240
Estee Lauder
EL
$39.6B
$1.64M 0.14%
20,329
-25,874
-56% -$1.66M
2025 Q1
1 quarter
CCJ icon
241
Cameco
CCJ
$33.5B
$1.63M 0.14%
21,931
-6,890
-24% -$368K
2025 Q1
1 quarter
POWI icon
242
Power Integrations
POWI
$2.45B
$1.62M 0.14%
29,037
+6,322
+28% +$324K
2023 Q3
7 quarters
ROCK icon
243
Gibraltar Industries
ROCK
$1.19B
$1.62M 0.14%
27,511
+2,044
+8% +$117K
2024 Q2
4 quarters
PCVX icon
244
Vaxcyte
PCVX
$9.8B
$1.62M 0.14%
49,873
+1,113
+2% +$36.5K
2025 Q1
1 quarter
VIK icon
245
Viking Holdings
VIK
$39.1B
$1.61M 0.14%
30,257
+22,188
+275% +$979K
2024 Q3
3 quarters
JOBY icon
246
Joby Aviation
JOBY
$4.88B
$1.61M 0.14%
152,190
-2,605
-2% -$18.9K
2023 Q4
6 quarters
LCID icon
247
Lucid Motors
LCID
$1.19B
$1.6M 0.14%
75,758
-21,314
-22% -$510K
2024 Q3
3 quarters
DGX icon
248
Quest Diagnostics
DGX
$27.8B
$1.59M 0.14%
+8,853
New +$1.54M
2025 Q2
0 quarters
DOCS icon
249
Doximity
DOCS
$5.84B
$1.58M 0.13%
25,779
-10,720
-29% -$598K
2024 Q4
2 quarters
HUM icon
250
Humana
HUM
$49.8B
$1.57M 0.13%
6,438
-10,627
-62% -$2.65M
2025 Q1
1 quarter

Similar funds

Nebula Research & Development's Q2 2025 Portfolio in Review

As of Q2 2025, Nebula Research & Development held 1,192 positions worth $1.17B, up 8.6% from $1.08B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

Nebula Research & Development's Q2 2025 filing shows 267 new, 346 increased, 321 reduced and 257 closed positions. Its largest new stake was Stride: 35,744 shares worth $5.19M. The largest sale was United Parcel Service, an estimated $4.82M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Nebula Research & Development's largest Q2 2025 buy was Stride: 35,744 shares worth $5.19M.
  • Nebula Research & Development added most to A.O. Smith in Q2 2025, an estimated $4.11M increase.
  • Nebula Research & Development's biggest Q2 2025 reduction was Agilent Technologies, cutting an estimated $4.12M.
  • Nebula Research & Development fully exited United Parcel Service in Q2 2025, selling an estimated $4.82M.
  • Nebula Research & Development's ten largest holdings make up 4.4% of its $1.17B portfolio in Q2 2025.
  • Nebula Research & Development opened 267 new positions and closed 257 in Q2 2025.
  • Nebula Research & Development's portfolio value rose 8.6% quarter-over-quarter to $1.17B.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.